drugset / Trial / NCT00217815
Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study hypothesis is that the addition of Mycograb to docetaxel will improve outcome in advanced carcinoma of the breast.
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efungumab | Monoclonal antibody | — | Intravenous |
| Background | Docetaxel | Small molecule | — | — |